Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Common Equity (2017 - 2025)

Selectis Health's Common Equity history spans 13 years, with the latest figure at -$5.7 million for Q3 2025.

  • For Q3 2025, Common Equity fell 16.92% year-over-year to -$5.7 million; the TTM value through Sep 2025 reached -$5.7 million, down 16.92%, while the annual FY2024 figure was -$5.4 million, 82.54% down from the prior year.
  • Common Equity for Q3 2025 was -$5.7 million at Selectis Health, up from -$6.4 million in the prior quarter.
  • Across five years, Common Equity topped out at $5.0 million in Q1 2023 and bottomed at -$6.4 million in Q2 2025.
  • The 5-year median for Common Equity is $952835.0 (2022), against an average of -$295359.9.
  • The largest annual shift saw Common Equity soared 684.92% in 2021 before it tumbled 814.25% in 2024.
  • A 5-year view of Common Equity shows it stood at $3.1 million in 2021, then crashed by 69.29% to $952835.0 in 2022, then tumbled by 411.05% to -$3.0 million in 2023, then plummeted by 82.54% to -$5.4 million in 2024, then decreased by 4.47% to -$5.7 million in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Common Equity are -$5.7 million (Q3 2025), -$6.4 million (Q2 2025), and -$6.1 million (Q1 2025).